Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection

Maurizio Pompili, Gian Ludovico Rapaccini, F De Luca, E Caturelli, Antonio Astone, Da Siena, Villani, A Grattagliano, A Cedrone, Giovanni Battista Gasbarrini

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) complicating cirrhosis has a high intrahepatic recurrence rate after treatment by surgical resection or percutaneous ethanol injection (PEI). In this study, certain clinical, biochemical, and pathologic parameters were evaluated as risk factors for intrahepatic tumor recurrence in liver segments different from that of the first neoplasm in a group of 57 cirrhotic patients with single HCC < 5 cm treated by PEI.
Original languageEnglish
Pages (from-to)1501-1508
Number of pages8
JournalCancer
Volume79
Publication statusPublished - 1997

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents
  • Carcinoma, Hepatocellular
  • Ethanol
  • Female
  • Follow-Up Studies
  • Humans
  • Italy
  • Liver Cirrhosis
  • Liver Neoplasms
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasms, Second Primary
  • Proportional Hazards Models
  • Risk Factors
  • Tumor Markers, Biological

Fingerprint

Dive into the research topics of 'Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection'. Together they form a unique fingerprint.

Cite this